× |
|
Bilateral Olfactory Bulb Atrophy in Post–COVID-19 Parosmia PDF |
$40.00 |
|
$40.00 |
× |
       |
Response and Relapse in Patients With Schizophrenia Treated With Olanzapine, Risperidone, Quetiapine, or Haloperidol: 12-Month Follow-Up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study PDF |
$40.00 |
|
$40.00 |
× |
       |
When to Refer to Palliative Care PDF |
$40.00 |
|
$40.00 |
× |
       |
Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
× |
       |
The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
× |
       |
"Bath Salts"-Induced Psychosis and Serotonin Toxicity PDF |
$40.00 |
|
$40.00 |
× |
       |
Converting From Intramuscular to Oral Risperidone in a Nursing Home Resident PDF |
$40.00 |
|
$40.00 |
|